Help:WikiPathways Portals
From WikiPathways
(Difference between revisions)
Current revision (13:11, 13 April 2022) (view source) |
|||
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
{| class="wikitable sortable" style="float:right; margin-left: 100px;" | {| class="wikitable sortable" style="float:right; margin-left: 100px;" | ||
|- | |- | ||
| - | |<h2 class="frontPagePanel blueFg">Community Featured Pathways IEM</h2>{{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Curation: | + | |<h2 class="frontPagePanel blueFg">Community Featured Pathways IEM</h2>{{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Curation:IEM | true}} |
|- | |- | ||
|<h2 class="frontPagePanel blueFg">Community Featured Pathways COVID-19</h2>{{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Curation:COVID19 | true}} | |<h2 class="frontPagePanel blueFg">Community Featured Pathways COVID-19</h2>{{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Curation:COVID19 | true}} | ||
| Line 23: | Line 23: | ||
* [[Portal:AOP|Adverse Outcome Pathway]] | * [[Portal:AOP|Adverse Outcome Pathway]] | ||
| - | * [[Portal:IEM|Inborn Errors of Metabolism (IEM)]] | + | * [[Portal:IEM|Inherited Metabolic Disorders (IMDs), or Inborn Errors of Metabolism (IEM)]] |
* [[Portal:CIRM|California Institute for Regenerative Medicine, CIRM]] | * [[Portal:CIRM|California Institute for Regenerative Medicine, CIRM]] | ||
* [[Portal:Disease/COVIDPathways|COVID-19]] | * [[Portal:Disease/COVIDPathways|COVID-19]] | ||
Current revision
Community Featured Pathways IEMEthylmalonic encephalopathy (Homo sapiens) Image does not exist Ethylmalonic encephalopathy  |
Community Featured Pathways COVID-19ACE2 inhibition leads to pulmonary fibrosis (Homo sapiens) Image does not exist ACE2 inhibition leads to pulmonary fibrosis |
Portals within WikiPathways serve as organizing points for communities with focused pathway interests. For example, a portal could organize pathways for a particular species or research area.
The main advantages of portals include:
- Simplified drawing and collecting your pathways
- Help to keep track of ‘works-in-progress’ with collaborators
- Help attribute credit for pathway authors and curators
- Attract new collaborators
- Help to define a community
Creating a portal is easy using existing templates available from WikiPathways.
If you are interested, please consult the portal maintenance guide and contact us for assistance.
WikiPathways has a growing list of portals:
- Adverse Outcome Pathway
- Inherited Metabolic Disorders (IMDs), or Inborn Errors of Metabolism (IEM)
- California Institute for Regenerative Medicine, CIRM
- COVID-19
- Clinical Proteomic Tumor Analysis Consortium, CPTAC
- Disease
- ExRNA
- Lipids
- Micronutrients
- Nanomaterials
- NetPath
- Plant Pathways
- Rare Disease
- Renal Genomics
- Reactome
- Skeletal Dysplasia
- WormBase
